FUTUREBIOTICS INC
10-Q, EX-27, 2000-07-14
DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Previous: FUTUREBIOTICS INC, 10-Q, 2000-07-14
Next: HVIDE MARINE INC, 424B3, 2000-07-14



<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
The schedule contains summary financial information extracted from the financial
statements and is qualified in its entirety by reference to such financial
statements.
</LEGEND>


<MULTIPLIER>                                   1,000


<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                              NOV-30-2000
<PERIOD-END>                                   MAY-31-2000
<CASH>                                                 102
<SECURITIES>                                             0
<RECEIVABLES>                                        1,494
<ALLOWANCES>                                            12
<INVENTORY>                                            687
<CURRENT-ASSETS>                                     3,547
<PP&E>                                                 478
<DEPRECIATION>                                         305
<TOTAL-ASSETS>                                       4,321
<CURRENT-LIABILITIES>                                   21
<BONDS>                                                  0
                                    0
                                              1
<COMMON>                                                 0
<OTHER-SE>                                           4,299
<TOTAL-LIABILITY-AND-EQUITY>                         4,321
<SALES>                                              3,249
<TOTAL-REVENUES>                                     3,249
<CGS>                                                2,078
<TOTAL-COSTS>                                        2,078
<OTHER-EXPENSES>                                         0
<LOSS-PROVISION>                                         0
<INTEREST-EXPENSE>                                       0
<INCOME-PRETAX>                                       (387)
<INCOME-TAX>                                          (318)
<INCOME-CONTINUING>                                    (69)
<DISCONTINUED>                                           0
<EXTRAORDINARY>                                          0
<CHANGES>                                                0
<NET-INCOME>                                           (69)
<EPS-BASIC>                                           (.08)
<EPS-DILUTED>                                         (.08)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission